Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Alector, Inc. | Director | Common Stock | 2.64M | $14.7M | $5.56 | Jun 14, 2023 | Direct |
Adagio Therapeutics, Inc. | Chief Executive Officer, Director, 10%+ Owner | Stock Option (Right to Buy) | 175K | Jan 30, 2022 | Direct | ||
Alector, Inc. | Director | Stock Option (right to buy) | 12.4K | Jun 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALEC | Alector, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
ALEC | Alector, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
IVVD | Adagio Therapeutics, Inc. | Jan 30, 2022 | 1 | $0 | 4 | Feb 1, 2022 | Chief Executive Officer, Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 10, 2021 | 4 | $0 | 4 | Aug 12, 2021 | Chief Executive Officer, Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Chief Executive Officer, Director, 10%+ Owner |
ALEC | Alector, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |